The European Commission (EC) has granted approval to Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric ...

Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...

Cambridge, UK-based biotech start-up Maxion Therapeutics, which is developing antibody-based KnotBody drugs for ion channel- ...

The American Academy of Dermatology (AAD) meeting last week continued to provide positive news, including from US biotech ...

US biotech Regenxbio (Nasdaq: RGNX) has successfully completed the BLA submission for its mucopolysaccharidosis II (MPS II) ...

USA-based Azurity Pharmaceuticals says it has completed its acquisition of Covis Group from existing investors and the ...

Fourteen public and private parties, including pharmaceutical companies Astellas (TYO: 4503) and Merck KGaA (MRK: DE), have developed a drug for a 'forgotten' tropical disease: schistosomiasis. This ...

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...

The US Food and Drug Administration (FDA) has announced its recommendations to vaccine manufacturers for the virus strains to ...

Innovent Biologics (HKEX: 01801) has gained approval in China for Sycume (teprotumumab), the country’s first IGF-1R antibody ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...